Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 6, 2002

View Archived Issues

Robust thermogenic responses elicited by new beta3-adrenoceptor agonists identified at GSK

Imunovir distribution agreement for North America extended

Curis reports evidence for a unique mechanism for the renal effects of BMP-7

Potent hypoglycemic and hypolipidemic agent interacting with PPARgamma identified at Takeda

Company Profile: Basilea Pharmaceutica

Bio-Technology General initiates phase I study of Puricase in gout

Pharmacia licenses Nastech's nasally administered apomorphine for ED & FSD

Prana awarded grant for research into age-related diseases

Once-daily one-tablet formulation of Sustiva approved

Fast track designation for Oncophage in metastatic melanoma

Transglutaminase inhibitor improves survival and symptoms in transgenic Huntington's disease mice

EMEA accepts vardenafil submission for treatment of ED

Initiation of phase I clinical trial of XR-11576 in treatment of solid tumors

Medtronic's Activa Parkinson's Control Therapy receives FDA approval

Efalizumab to be evaluated in rheumatoid arthritis

New Janssen compounds with fundic relaxant activity

Polymer-based analgesic successfully completes first clinical trial at A.P. Pharma

AstraZeneca claims compounds which modulate chemokine receptors

AtheroGenics identifies inhibitors of VCAM-1 expression

Servier scientists prepare novel podophyllotoxin derivatives for cancer Rx

Potent and selective PDE7 inhibitors discovered at Celltech

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026